Mary Dilorenzo, NP
Nurse Practitioner · Charlotte, NCNPI 1437499506
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 28.7% of the total. 2025 is the largest year on record at $26,209, more than ten times the $1,222 reported in 2021. Among nurse practitioner clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 147 payments — averaging $480.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$20K
- Johnson & Johnson$13K
- AstraZeneca$10K
- Genmab U.S., Inc.$7K
- Pharmacyclics LLC, An Abbvie Company$7K
- AbbVie$6K
- plus $6K from 11 others
What the payments were for
- Consulting fees$10,30315%
- Speaking & faculty fees$37,67653%
- Travel & lodging$17,14224%
- Food & beverage$5,4008%
- Education$890%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 42 | $20,239 |
| Johnson & Johnson | 15 | $13,169 |
| AstraZeneca | 25 | $10,269 |
| Genmab U.S., Inc. | 15 | $7,331 |
| Pharmacyclics LLC, An Abbvie Company | 7 | $6,833 |
| AbbVie | 13 | $6,469 |
| Incyte Corporation | 15 | $4,392 |
| Gilead | 1 | $625 |
| Adaptive Biotechnologies Corporation | 3 | $374 |
| GSK | 2 | $227 |
| ADC Therapeutics America, Inc. | 1 | $143 |
| Beigene USA, Inc. | 1 | $125 |
| Sanofi | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 1 | $110 |
| TG Therapeutics, Inc. | 1 | $96 |
| Bristol Myers Squibb | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$70,610 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JaypircaPirtobrutinib | 14 | $284,223 |
| ValacyclovirValacyclovir Hcl | 72 | $4,543 |
| Dexamethasone | 21 | $299 |
| Ondansetron Hcl | 16 | $196 |
| Levofloxacin | 24 | $181 |
| Prochlorperazine Maleate | 13 | $155 |
| Gabapentin | 11 | $129 |
| Potassium Chloride | 18 | $118 |
| Pantoprazole Sodium | 30 | $96 |
| Tramadol Hcl | 19 | $86 |
| Fluconazole | 14 | $82 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 21 | $71 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $67 |
| Escitalopram Oxalate | 12 | $64 |
| Lorazepam | 17 | $27 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Charlotte
- Dennis TaylorCharlotte$39K
- Geovanna DeeseCharlotte$26K
- Melissa TharpeCharlotte$24K
- Marie MooreCharlotte$21K
- Natasha LaunganiCharlotte$18K
- Vicki MortonCharlotte$18K
- Courtney CarrCharlotte$18K
- Travis ShipeCharlotte$17K
- Kelly XiongCharlotte$16K
- Christina ChristensenCharlotte$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.